Volume 78, Issue 10, Pages (November 2010)

Slides:



Advertisements
Similar presentations
Renal registry in Hong Kong—the first 20 years Chi Bon Leung, Wai Lun Cheung, Philip Kam Tao Li Kidney International Supplements Volume 5, Issue 1, Pages.
Advertisements

Kamyar Kalantar-Zadeh  Kidney International 
Treatment of Early Immunoglobulin A Nephropathy by Angiotensin-converting Enzyme Inhibitor  Philip Kam-Tao Li, MD, Bonnie Ching-Ha Kwan, MBBS, Kai-Ming.
Long-term follow-up of patients randomized to biocompatible or conventional peritoneal dialysis solutions show no difference in peritonitis or technique.
Volume 80, Issue 10, Pages (November 2011)
C-reactive protein and dialysis access
John P. Middleton, Patrick H. Pun  Kidney International 
Volume 62, Issue 2, Pages (August 2002)
Long term outcome of patients with autosomal dominant polycystic kidney diseases receiving peritoneal dialysis  Sanjeev Kumar, Stanley L.-S. Fan, Martin.
Volume 80, Issue 4, Pages (August 2011)
Kamyar Kalantar-Zadeh  Kidney International 
Jeffrey C. Fink, Glenn M. Chertow  Kidney International 
Steroid-free maintenance immunosuppression in kidney transplantation: is it time to consider it as a standard therapy?  Fu L. Luan, Diane E. Steffick,
The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age  B.O. Eriksen, O.C. Ingebretsen  Kidney International 
Nephrology image: quadriceps rupture
Comorbidity and confounding in end-stage renal disease
Volume 74, Issue 3, Pages (August 2008)
Anti-glomerular basement membrane autoantibodies against different target antigens are associated with disease severity  Juan Zhao, Zhao Cui, Rui Yang,
Punit Yadav, Nelson Leung, Paul W. Sanders, Paul Cockwell 
Volume 61, Issue 6, Pages (June 2002)
Volume 73, Issue 7, Pages (April 2008)
Volume 85, Issue 6, Pages (June 2014)
Bradley A. Ford, Daniel W. Coyne, Charles S. Eby, Mitchell G. Scott 
Volume 76, Issue 10, Pages (November 2009)
Peritoneal dialysis in patients with dementia
The analysis of survival data: the Kaplan–Meier method
Volume 59, Issue 4, Pages (April 2001)
Quiz Page December 2010 American Journal of Kidney Diseases
Volume 82, Issue 3, Pages (August 2012)
Response to ‘Hepcidin levels in patients with renal disease’
Volume 73, Issue 12, Pages (June 2008)
Volume 85, Issue 3, Pages (March 2014)
Correlation between time to positivity of blood cultures with clinical presentation and outcomes in patients with Klebsiella pneumoniae bacteraemia: prospective.
Volume 80, Issue 12, Pages (December 2011)
Volume 66, Issue 2, Pages (August 2004)
Linda F. Fried, Trevor J. Orchard, Bertram L. Kasiske 
Volume 85, Issue 5, Pages (May 2014)
Methods for guideline development
Racial disparities in access to transplantation: a tough nut to crack
Volume 76, Issue 8, Pages (October 2009)
Counteracting progression of renal disease: A look into the future
Nephrology Crossword: Glomerulonephritis
Volume 76, Issue 8, Pages (October 2009)
Volume 85, Issue 5, Pages (May 2014)
Antiglomerular basement membrane disease with normal renal function
Circadian regulation of renal function
Volume 82, Issue 9, Pages (November 2012)
Muscle infarction in peritoneal dialysis patients1
Volume 77, Issue 11, Pages (June 2010)
Free serum concentrations of the protein-bound retention solute p-cresol predict mortality in hemodialysis patients  B. Bammens, P. Evenepoel, H. Keuleers,
Volume 58, Issue 1, Pages (July 2000)
Low triiodothyronine and survival in end-stage renal disease
Volume 80, Issue 10, Pages (November 2011)
Volume 80, Issue 10, Pages (November 2011)
Treatment of the primary hyperoxalurias: A new chapter
Volume 74, Issue 7, Pages (October 2008)
Charles A. Herzog  Kidney International 
The hypothesis that abnormal BH4 metabolism impairs kidney function
Is complement a target for therapy in renal disease?
Volume 83, Issue 3, Pages (March 2013)
Volume 69, Issue 7, Pages (April 2006)
Membranous nephropathy: recent travels and new roads ahead
Volume 82, Issue 9, Pages (November 2012)
Volume 70, Issue 10, Pages (November 2006)
Abby S. Kazley, Kit N. Simpson, Kenneth D. Chavin, Prabhakar Baliga 
Volume 65, Issue 5, Pages (May 2004)
Prediction in idiopathic membranous nephropathy
Volume 83, Issue 1, Pages (January 2013)
The Ebf1 knockout mouse and glomerular maturation
Epidemiologic data of renal diseases from a single unit in China: Analysis based on 13,519 renal biopsies  Lei-Shi Li, Zhi-Hong Liu  Kidney International 
Presentation transcript:

Volume 78, Issue 10, Pages 1041-1046 (November 2010) The width of the basement membrane does not influence clinical presentation or outcome of thin glomerular basement membrane disease with persistent hematuria  Cheuk-Chun Szeto, Fernand Mac-Moune Lai, Bonnie Ching-Ha Kwan, Chi-Bon Leung, Paul Cheung-Lung Choi, Wing-Fai Pang, Kai- Ming Chow, Ka-Bik Lai, Gang Wang, Philip Kam-Tao Li  Kidney International  Volume 78, Issue 10, Pages 1041-1046 (November 2010) DOI: 10.1038/ki.2010.285 Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 1 Kaplan–Meier plot of event-free survival. (a) Any detectable proteinuria; (b) proteinuria ≥1 g/day; (c) hypertension; and (d) impaired renal function. Data were compared using the log-rank test. TBMD, thin basement membrane disease. Kidney International 2010 78, 1041-1046DOI: (10.1038/ki.2010.285) Copyright © 2010 International Society of Nephrology Terms and Conditions

Figure 2 GBM thickness with and without events. Comparison of glomerular basement membrane (GBM) thickness between patients with and without (a) detectable proteinuria; (b) overt proteinuria; (c) hypertension; and (d) impaired renal function. Whisker box plot with boxes indicates median and 25 and 75 percentiles; whisker caps indicate 5 and 95 percentiles; and closed circles indicate outliers. Data were compared using Student's t-test. Kidney International 2010 78, 1041-1046DOI: (10.1038/ki.2010.285) Copyright © 2010 International Society of Nephrology Terms and Conditions